Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Tg Therapeutics (TGTX) Long-Term Debt Issuances (2019 - 2024)

Tg Therapeutics has reported Long-Term Debt Issuances over the past 3 years, most recently at $244.8 million for Q3 2024.

  • Quarterly results put Long-Term Debt Issuances at $244.8 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $244.8 million (changed 0.0% YoY), and the annual figure for FY2024 was $244.8 million, up 879.26%.
  • Long-Term Debt Issuances for Q3 2024 was $244.8 million at Tg Therapeutics, up from $25.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for TGTX hit a ceiling of $244.8 million in Q3 2024 and a floor of $25.0 million in Q1 2023.